Abstract
Background
Palliative resection for noncurable gastric cancer remains controversial, especially in the elderly. This retrospective study was designed to elucidate the clinicopathological factors and operative outcome in patients undergoing palliative gastric resection.
Methods
From January 1988 to December 2008, 365 patients received palliative gastrectomy while 151 underwent exploratory laparotomy or gastrojejunostomy for noncurative gastric cancer at the Department of Surgery, Taipei Veterans General Hospital. Among the 365 patients, 182 patients (Group A) were aged 70 or less and 183 patients (Group B) were older than 70 years of age. Clinicopathological characteristics and surgical morbidity and mortality were analyzed.
Results
The overall survival of patients who underwent resection was 10.2 months and that of patients without resection 4.48 months (p < 0.001). Compared to Group B, Group A patients were predominantly female (p < 0.001), had more advanced Borrmann-type tumors (p = 0.004), more diffuse type of Lauren classification (p < 0.001), and poorer cell differentiation (p < 0.001). The median overall survival was 10.5 months in Group A and 9.7 months in Group B (p = 0.854). The surgical morbidity was significant higher if the patients had comorbidity (p = 0.028). Both surgical morbidity (13.8% vs. 26.8%, p = 0.028) and mortality (0.5% vs. 6.0%, p < 0.0001) were significantly higher in Group B.
Conclusions
Gastric cancer is less aggressive in the elderly. Palliative gastrectomy can be performed in both younger and older patients, but younger patients tolerate surgery better. More attention should be paid to the perioperative care of the elderly.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Taiwan Public Health Report 2008, Department of Health, Executive Yuan, R.O.C. (Taiwan)
Wu CW, Hsiung CA, Lo SS et al (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309–315
Hartgrink HH, van de Velde CJH, Putter H et al (2004) Extended lymph-node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069–2077
Coniglio A, Massimo Tiberio GA, Busti M et al (2004) Surgical treatment for gastric carcinoma in the elderly. J Surg Oncol 88:201–205
Hartgrink HH, Putter H, Kranenbarg EK et al (2002) Value of palliative resection in gastric cancer. Br J Surg 89:1438–1443
Bonenkamp JJ, Sasako M, Hermans J et al (2001) Tumor load and surgical palliation in gastric cancer. Hepatogastroenterology 48:1219–1221
Medina-Franco H, Contreras-Saldivar A, Ramos-De La Medina A et al (2004) Surgery for stage IV gastric cancer. Am J Surg 187:534–536
American Joint Committee on Cancer (AJCC) (2003) Cancer staging manual, 6th edn. Springer-Verlag, New York
Saidi RF, ReMine SG, Dudrick PS et al (2006) Is there a role for palliative gastrectomy in patients with stage IV gastric cancer? World J Surg 30:21–27
Sarela AI, Yelluri S, Leeds Upper Gastrointestinal Cancer Multidisciplinary Team (2007) Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary. Arch Surg 142:143–149
Martella B, Militello C, Spirch S et al (2005) Palliative surgery for gastric cancer in elderly patients. Acta Biomed 76(Suppl 1):49–51
Nazli O, Yaman I, Tansug T et al (2007) Palliative surgery for advanced stage (stage IV) gastric adenocarcinoma. Hepatogastroenterology 54:298–303
Lo CH, Chen JH, Wu CW et al (2008) Risk factors and management of intra-abdominal infection after extended radical gastrectomy. Am J Surg 196:741–745
Wu CW, Chen Y, Hsieh MC et al (1992) Use of a modified Foley catheter for continuous irrigation of intra-abdominal abscess. Br J Surg 79:1296
Boddie AW, McMurtrey MJ, Giacco GG et al (1983) Palliative gastrectomy and esophagogastrectomy. A reevaluation. Cancer 51:1195–1200
Samarasam I, Chandran BS, Sitaram V et al (2006) Palliative gastrectomy in advanced gastric cancer. ANZ J Surg 76:60–63
Jeung HC, Rha SY, Jang WI et al (2002) Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. Br J Surg 89:460–466
Lin SZ, Tong HF, You T et al (2008) Palliative gastrectomy and chemotherapy for stage IV gastric cancer. J Cancer Res Clin 134:187–192
Cunningham D, Rao S, Nicolson M et al (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358:36–46
Okines AFC, Norman AR, McCloud C et al (2009) Meta-analysis of the REAL-2 and ML-17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. Ann Oncol 20:1529–1534
Gravalos C, Jimeno A (2008) Her2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 19:1523–1529
Lee SE, Kim YW, Lee JH et al (2009) Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Ann Surg 16:2231–2236
Kawamura H, Homma S, Yokota R et al (2008) Inspection of safety and accuracy of D2 lymph node dissection in laparoscopy-assisted distal gastrectomy. World J Surg 32:2366–2370
Miner TJ, Jaques DP, Karpeh MS et al (2004) Defining palliative surgery in patients receiving noncurative resection for gastric cancer. J Am Coll Surg 198:1013–1021
Kahlke V, Bestmann B, Schmid A (2004) Palliation of metastatic gastric cancer: impact of preoperative symptoms and quality of life. World J Surg 28:369–375
Cunningham SS, Schulick RD (2007) Palliative management of gastric cancer. Surg Oncol 16:267–275
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, KH., Wu, CW., Fang, WL. et al. Palliative Resection in Noncurative Gastric Cancer Patients. World J Surg 34, 1015–1021 (2010). https://doi.org/10.1007/s00268-010-0467-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-010-0467-7